MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4

  • Authors:
    • Ke Mao
    • Ding Lei
    • Heng Zhang
    • Chao You
  • View Affiliations

  • Published online on: September 14, 2017     https://doi.org/10.3892/ijo.2017.4122
  • Pages: 1521-1532
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioblastoma (GBM), which is characterised by rapid growth, cellular heterogeneity, angiogenesis, extensive invasion, hypoxia and necrosis, is the most common histological subtype of glioma in adults. MicroRNA (miRNA) dysregulation is a common feature of human cancers, including GBM. Previous studies have suggested that miRNAs are a novel class of regulatory molecules in various human cancers. Therefore, miRNAs may be investigated as a novel candidate and screening tool in the clinical diagnosis, therapy and prognosis of GBM. Recent accumulating evidence has demonstrated that miRNA‑485 (miR‑485) is involved in the development and progression of several types of human cancers. However, the expression level, exact role and underlying mechanisms of miR‑485 in GBM remain unclear. In this study, miR‑485 was downregulated in both GBM tissue specimens and cell lines. miR‑485 overexpression inhibited GBM cell proliferation, colony formation, migration and invasion; increased apoptosis in vitro; and reduced tumour growth in vivo. In addition, p21‑activated kinase 4 (PAK4) was demonstrated to be a direct and functional target of miR‑485 in GBM. Furthermore, PAK4 was upregulated in GBM tissues and negatively correlated with miR‑485 expression. Moreover, PAK4 knockdown exhibited a similar effect to miR‑485 overexpression in GBM cells. Enforced expression of PAK4 rescued miR‑485 tumour‑suppressor functions in GBM cells. miR‑485 inhibited the activation of the AKT and ERK signalling pathways in GBM. These results indicate that miR‑485 acts as a tumour suppressor in GBM by, at least partially, directly targeting PAK4 and regulating the AKT and ERK signalling pathways. Thus, miR‑485 may be a potential target for the treatment of patients with GBM.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 51 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Mao K, Lei D, Zhang H and You C: MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4. Int J Oncol 51: 1521-1532, 2017
APA
Mao, K., Lei, D., Zhang, H., & You, C. (2017). MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4. International Journal of Oncology, 51, 1521-1532. https://doi.org/10.3892/ijo.2017.4122
MLA
Mao, K., Lei, D., Zhang, H., You, C."MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4". International Journal of Oncology 51.5 (2017): 1521-1532.
Chicago
Mao, K., Lei, D., Zhang, H., You, C."MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4". International Journal of Oncology 51, no. 5 (2017): 1521-1532. https://doi.org/10.3892/ijo.2017.4122